Former institutional trader Kevin Muir flags caution on chasing this market as he sees some big market whales nearing the end ...

While it has been nearly three months since gold climbed past $3,500 an ounce to its highest price on record, five key ...

China’s central bank has been buying physical gold to add to its reserves for at least the last three years  – and there’s ...

Scott Rubner, a former Goldman Sachs tactical strategist now at Citadel Securities, said it’s too soon to fade the stock ...

A Starbucks rally has run too far, says one brokerage that slapped an underperform rating on the coffee retailer.

The 2025 Toyota Corolla Cross Hybrid is a small and fuel-efficient SUV with a good amount of standard equipment. Pricing ...

George and Amal Clooney are used to being at the center of media attention, and the scrutiny has prompted them to take ...

Abbott Labs trimmed and narrowed its guidance for the year while reporting strong profit and sales gains in the second quarter.

Clearside Biomedical will divert all employees to a consulting status and halt research-and-development, allowing the eye-care biotechnology firm to conserve cash during a search for a deal or other ...

For the latest period, U.S. Bancorp narrowed its provision for credit losses to $501 million from $537 million in the prior quarter and $568 million a year earlier. The decline reflected ...

Rocket Pharmaceuticals received a regenerative medicine advanced therapy designation from the Food and Drug Administration for its heart disease treatment.

SALES FORECAST: The British trench-coat maker is expected to report a 3% decrease in comparable retail sales for the first three months, according to a company-compiled poll of estimates by 16 ...